Adding pharmacogenomics to the development of new marine-derived anticancer agents
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Adding pharmacogenomics to the development of new marine-derived anticancer agents ; volume:4 ; number:1 ; day:09 ; month:1 ; year:2006 ; pages:1-9 ; date:6.2006
Journal of translational medicine ; 4, Heft 1 (09.1.2006), 1-9, 6.2006
- Urheber
-
Jimeno, José
- Beteiligte Personen und Organisationen
-
Aracil, Miguel
Tercero, Juan Carlos
SpringerLink (Online service)
- DOI
-
10.1186/1479-5876-4-3
- URN
-
urn:nbn:de:1111-2016041431412
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Jimeno, José
- Aracil, Miguel
- Tercero, Juan Carlos
- SpringerLink (Online service)
Ähnliche Objekte (12)
Copy number polymorphisms and anticancer pharmacogenomics
Anticancer Drug Discovery: Role of Pharmacogenomics
Heterocyclic anticancer agents
Pharmacogenomics
Molecular mechanisms and pharmacogenomics of constituents of Salvia miltiorrhiza for anticancer therapy
Thiadiazole derivatives as anticancer agents
Adding animated presentation agents to the interface
6th Golden Helix Pharmacogenomics Day: pharmacogenomics and individualized therapy
The pharmacogenomics journal
Pharmacogenomics and toxicogenomics
Pharmacogenomics and toxicogenomics
Clinical use of pharmacogenomics
Copy number polymorphisms and anticancer pharmacogenomics
Anticancer Drug Discovery: Role of Pharmacogenomics
Heterocyclic anticancer agents
Pharmacogenomics
Molecular mechanisms and pharmacogenomics of constituents of Salvia miltiorrhiza for anticancer therapy
Thiadiazole derivatives as anticancer agents
Adding animated presentation agents to the interface
6th Golden Helix Pharmacogenomics Day: pharmacogenomics and individualized therapy
The pharmacogenomics journal
Pharmacogenomics and toxicogenomics
Pharmacogenomics and toxicogenomics
Clinical use of pharmacogenomics
Copy number polymorphisms and anticancer pharmacogenomics
Anticancer Drug Discovery: Role of Pharmacogenomics
Heterocyclic anticancer agents
Pharmacogenomics
Molecular mechanisms and pharmacogenomics of constituents of Salvia miltiorrhiza for anticancer therapy
Thiadiazole derivatives as anticancer agents
Adding animated presentation agents to the interface
6th Golden Helix Pharmacogenomics Day: pharmacogenomics and individualized therapy
The pharmacogenomics journal
Pharmacogenomics and toxicogenomics
Pharmacogenomics and toxicogenomics